Clinical Trials Browser

Phase EARLY_PHASE1 × Recurrence × Topotecan × Clear all

NCT06972602 2025-05-15

High-dose Topotecan for Retinoblastoma With Recurrent or Refractory Vitreous Seed

Phase EARLY_PHASE1 Recruiting

Other solid neoplasm

Recurrence, Retinoblastoma